Verséa
Verséa
Home
About
About Us
Mission & Values
Our History
Our Standards
Leadership
Scientific Advisors
Careers
Business Units
Diagnostics
POC Professional
OTC Consumer
Virtual Health
Therapeutics
Wellness
Ophthalmics
T-POC Testing Platform
Biovance 3L Ocular
Resources
Discovery
VCX™ Discovery Platform
AgroTech
Partnerships
News
Corporate
Diagnostics
Therapeutics
Ophthalmics
Discovery
Home
Elements
Blog Layouts
OUR NEWS
Masonry Post Grid
All
Biologics
Corporate
Diagnostics
Discovery
News
Ophthalmics
Therapeutics
OUR NEWS
Latest Posts
27 July 2023
Verséa Ophthalmics and Celularity Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance® and Biovance® 3L Ocular for Ophthalmic Applications
25 July 2023
Verséa Ophthalmics Commences Phase 1 Launch of Novel Tear-based Point-of-Care (T-POC) Quantitative Testing Platform
28 June 2023
Verséa Health and iRemedy Announce Strategic Joint Venture